Dougherty Ryne W, McDonald Jennifer S, Cho Yong Woon, Wald John T, Thielen Kent R, Kallmes David F
Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA.
J Neurointerv Surg. 2014 Jan;6(1):57-60. doi: 10.1136/neurintsurg-2012-010599. Epub 2013 Jan 23.
Sacroplasty has emerged as a treatment option for patients with painful osteoporotic sacral insufficiency fractures. We report short-term outcomes in a consecutive cohort of patients treated with sacroplasty.
We retrospectively reviewed 57 patients treated with sacroplasty for painful osteoporotic sacral fractures at our institution between 2004 and 2011. An 11-point numerical rating scale pain score was recorded at rest and at activity pre- and post-procedure. Opioids prescribed to the patient both pre- and post-procedure were recorded.
Mean duration of pain prior to sacroplasty was 3 weeks (IQR 2-5). Procedural complications were minimal. Median post-procedure follow-up time was 2.5 weeks (IQR 1-5) among 45 patients with available data. Thirty-seven (82%) of the 45 patients experienced a numerical or descriptive decrease from initial pain at follow-up. Median activity pain scores collected from 13 patients decreased from 10 (IQR 8.5-10) pre-procedure to 6 (IQR 4-6.8) post-procedure (p<0.0001), and median rest pain scores collected from 29 patients decreased from 7 (IQR 4-8.5) to 2 (IQR 1-3.5)(p<0.0001). Twenty-two (76%) of 29 patients had at least a 30% decrease in rest pain scores. The median number of opioids prescribed per patient decreased from 1 (IQR 1-2) pre-procedure to 0 (IQR 0-1) post-procedure (p<0.0001). Thirty-four of 57 patients (60%) had decreased opioid usage, 15 (26%) patients had unchanged usage and 8 (14%) had increased usage.
Our series demonstrates that sacroplasty is a safe and effective treatment in patients with painful osteoporotic insufficiency fractures.
骶骨成形术已成为治疗疼痛性骨质疏松性骶骨不全骨折患者的一种治疗选择。我们报告了接受骶骨成形术治疗的连续队列患者的短期疗效。
我们回顾性分析了2004年至2011年在我院接受骶骨成形术治疗疼痛性骨质疏松性骶骨骨折的57例患者。记录术前和术后静息及活动时的11分数字评分量表疼痛评分。记录患者术前和术后开具的阿片类药物。
骶骨成形术前疼痛的平均持续时间为3周(四分位间距2 - 5周)。手术并发症极少。45例有可用数据的患者术后中位随访时间为2.5周(四分位间距1 - 5周)。45例患者中有37例(82%)在随访时疼痛较初始时出现数字或描述性减轻。13例患者收集的活动疼痛评分中位数从术前的10分(四分位间距8.5 - 10分)降至术后的6分(四分位间距4 - 6.8分)(p<0.0001),29例患者收集的静息疼痛评分中位数从7分(四分位间距4 - 8.5分)降至2分(四分位间距1 - 3.5分)(p<0.0001)。29例患者中有22例(76%)静息疼痛评分至少降低了30%。每位患者开具的阿片类药物中位数从术前的1种(四分位间距1 - 2种)降至术后的0种(四分位间距0 - 1种)(p<0.0001)。57例患者中有34例(60%)阿片类药物使用量减少,15例(26%)患者使用量不变,8例(14%)患者使用量增加。
我们的系列研究表明,骶骨成形术是治疗疼痛性骨质疏松性不全骨折患者的一种安全有效的治疗方法。